Progress of the application clinical prediction model in polycystic ovary syndrome
- PMID: 38007488
- PMCID: PMC10675861
- DOI: 10.1186/s13048-023-01310-2
Progress of the application clinical prediction model in polycystic ovary syndrome
Abstract
Clinical prediction models play an important role in the field of medicine. These can help predict the probability of an individual suffering from disease, complications, and treatment outcomes by applying specific methodologies. Polycystic ovary syndrome (PCOS) is a common disease with a high incidence rate, huge heterogeneity, short- and long-term complications, and complex treatments. In this systematic review study, we reviewed the progress of clinical prediction models in PCOS patients, including diagnosis and prediction models for PCOS complications and treatment outcomes. We aimed to provide ideas for medical researchers and clues for the management of PCOS. In the future, models with poor accuracy can be greatly improved by adding well-known parameters and validations, which will further expand our understanding of PCOS in terms of precision medicine. By developing a series of predictive models, we can make the definition of PCOS more accurate, which can improve the diagnosis of PCOS and reduce the likelihood of false positives and false negatives. It will also help discover complications earlier and treatment outcomes being known earlier, which can result in better outcomes for women with PCOS.
Keywords: Application progress; Clinical prediction model; Endocrine; Overweight PCOS; Polycystic ovary syndrome; Reproduction.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Does metformin improve reproduction outcomes for non-obese, infertile women with polycystic ovary syndrome? Meta-analysis and systematic review.Eur J Obstet Gynecol Reprod Biol. 2022 Apr;271:38-62. doi: 10.1016/j.ejogrb.2022.01.025. Epub 2022 Feb 1. Eur J Obstet Gynecol Reprod Biol. 2022. PMID: 35149444
-
Ovarian surgery for symptom relief in women with polycystic ovary syndrome.Cochrane Database Syst Rev. 2017 Nov 10;11(11):CD009526. doi: 10.1002/14651858.CD009526.pub2. Cochrane Database Syst Rev. 2017. PMID: 29125183 Free PMC article.
-
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.Cochrane Database Syst Rev. 2017 Nov 29;11(11):CD003053. doi: 10.1002/14651858.CD003053.pub6. Cochrane Database Syst Rev. 2017. PMID: 29183107 Free PMC article.
-
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.Cochrane Database Syst Rev. 2022 Sep 27;9(9):CD010287. doi: 10.1002/14651858.CD010287.pub4. Cochrane Database Syst Rev. 2022. PMID: 36165742 Free PMC article.
-
High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.Hum Reprod. 2017 May 1;32(5):1075-1091. doi: 10.1093/humrep/dex044. Hum Reprod. 2017. PMID: 28333286
Cited by
-
Harnessing Microbiome, Bacterial Extracellular Vesicle, and Artificial Intelligence for Polycystic Ovary Syndrome Diagnosis and Management.Biomolecules. 2025 Jun 7;15(6):834. doi: 10.3390/biom15060834. Biomolecules. 2025. PMID: 40563474 Free PMC article. Review.
-
Cross-talk between oxidative stress and lipid metabolism regulators reveals molecular clusters and immunological characterization in polycystic ovarian syndrome.Lipids Health Dis. 2024 Aug 15;23(1):248. doi: 10.1186/s12944-024-02237-3. Lipids Health Dis. 2024. PMID: 39143634 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical